TAILIN: 2021, Zhejiang Tailin Biotechnology Co., Ltd. issued convertible corporate bonds on the Growth Enterprise Market to unspecified parties. This report tracks the rating until 2024.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.